Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression in adolescence.

S M Sampson1, D A Mrazek

  • 1Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Current Opinion in Pediatrics
|December 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using a pharmacogenomic algorithm to guide the treatment of depression.

Translational psychiatry·2012
Same author

Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics.

The pharmacogenomics journal·2012
Same author

Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.

Clinical pharmacology and therapeutics·2010
Same author

Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.

The pharmacogenomics journal·2010
Same author

SLC6A4 variation and citalopram response.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics·2008
Same author

Genetic and environmental influences on the associations between attention problems and other problem behaviors.

Twin research : the official journal of the International Society for Twin Studies·2002
Same journal

For health, for beauty, or both? navigating trends as adolescent clinicians.

Current opinion in pediatrics·2026
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
See all related articles

Major depression in adolescents poses a high risk for adult recurrence and suicide. This review covers depression risks, subtypes, identification challenges, and biologic therapies for adolescent depression.

Area of Science:

  • Adolescent psychiatry
  • Mental health research
  • Developmental psychology

Background:

  • Major depression is a prevalent adolescent disorder with long-term implications.
  • Adolescent depression significantly elevates the risk of suicidal ideation and attempts.
  • Suicide remains a leading cause of death among adolescents.

Purpose of the Study:

  • To review the risks associated with adolescent depression and suicidal ideation.
  • To discuss various subtypes of depression in adolescents.
  • To examine the challenges in identifying depression and suicidal ideation in this population.
  • To review available biologic therapies for adolescent depression.

Main Methods:

  • Literature review of existing research on adolescent depression.

Related Experiment Videos

  • Analysis of risk factors for depression and suicidal ideation.
  • Discussion of diagnostic challenges in adolescent mental health.
  • Overview of current biologic treatment options.

    • Main Results:

    • Adolescent depression is a strong predictor of adult recurrence.
    • Depression is a key risk factor for adolescent suicide.
    • Identification of depression and suicidal ideation in adolescents presents unique difficulties.
    • Biologic therapies offer potential treatment avenues for adolescent depression.

    Conclusions:

    • Early identification and intervention for adolescent depression are crucial.
    • Understanding depression subtypes can inform treatment strategies.
    • Addressing identification challenges is vital for effective mental healthcare.
    • Biologic therapies warrant further investigation for adolescent depression management.